# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001159036-25-000010
Filing Date
2025-02-18
Accepted
2025-02-18 16:17:19
Documents
116
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | halo-20241231.htm iXBRL | 10-K | 2226741
2 | EX-19.1 | ex191insidertradingpolicy.htm | EX-19.1 | 104125
3 | EX-21.1 | ex211subsidiaries2024.htm | EX-21.1 | 6150
4 | EX-23.1 | ex231auditorconsent2024.htm | EX-23.1 | 5653
5 | EX-31.1 | ex31110kq42024.htm | EX-31.1 | 12949
6 | EX-31.2 | ex31210kq42024.htm | EX-31.2 | 12889
7 | EX-32 | ex3210kq42024.htm | EX-32 | 13901
13 | GRAPHIC | halo-20241231_g1.jpg | GRAPHIC | 15840
14 | GRAPHIC | halo-20241231_g2.jpg | GRAPHIC | 2311182
15 | GRAPHIC | halo-20241231_g3.jpg | GRAPHIC | 606117
16 | GRAPHIC | halo-20241231_g4.jpg | GRAPHIC | 111980
| Complete submission text file | 0001159036-25-000010.txt |  | 19335233

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20241231.xsd | EX-101.SCH | 75872
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | halo-20241231_cal.xml | EX-101.CAL | 136020
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20241231_def.xml | EX-101.DEF | 394149
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20241231_lab.xml | EX-101.LAB | 1017468
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20241231_pre.xml | EX-101.PRE | 716966
119 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20241231_htm.xml | XML | 1879881

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32335 | Film No.: 25635110
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)